Alpha Tau Medical (NASDAQ: DRTS) director discloses initial shares, RSUs and option grants
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Alpha Tau Medical Ltd. director Alon Ruth filed an initial ownership report detailing his equity position in the company. He directly holds 29,367 ordinary shares, 4,680 restricted share units that vest in full upon the earlier of one year from March 9, 2026 or the next annual shareholder meeting, and multiple option grants over ordinary shares with exercise prices between $2.98 and $10.92. According to the footnotes, certain options are already fully vested, while others vest on the same future schedule as the restricted share units, all subject to his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Alon Ruth
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
Holdings After Transaction:
Options — 8,945 shares (Direct);
Ordinary Shares — 29,367 shares (Direct);
Restricted Share Units — 4,680 shares (Direct)
Footnotes (1)
- These ordinary shares represent restricted share units, which will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service. These are options to acquire ordinary shares, which have fully vested as of the date hereof. These are options to acquire ordinary shares, which options will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
FAQ
What does the Alpha Tau Medical (DRTS) Form 3 filing for Alon Ruth show?
The Form 3 shows Alon Ruth’s initial ownership in Alpha Tau Medical. He holds ordinary shares, restricted share units vesting around March 9, 2026, and several option grants with exercise prices between $2.98 and $10.92, reflecting his equity-based alignment with the company.
Are Alon Ruth’s Alpha Tau Medical (DRTS) equity awards fully vested?
The filing states that some options are fully vested, while other options and restricted share units vest later. Unvested awards will vest in full upon the earlier of one year from March 9, 2026 or the next annual shareholder meeting, subject to continued service.